Literature DB >> 9158539

Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.

J Chamberlain1, J Melia, S Moss, J Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9158539     DOI： 10.1111/j.1464-410x.1997.tb16914.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  11 in total

1.  Prostate cancer screening.

Authors:  R R Hall; F Alexander
Journal:  J R Soc Med       Date:  1998-09       Impact factor: 5.344

2.  What urologists say they do for men with prostate cancer.

Authors:  M Emberton
Journal:  BMJ       Date:  1999-01-30

3.  Screening for prostate cancer: estimating the magnitude of overdetection.

Authors:  M McGregor; J A Hanley; J F Boivin; R G McLean
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

4.  Latest tests for prostatic neoplasia.

Authors:  W J Marshall
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

5.  Health technology assessment--the role of the pharmaceutical panel.

Authors:  T Walley; M Rawlins; K Stein
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

6.  Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany.

Authors:  Nikolaus Becker; Hans-Peter Altenburg; Christa Stegmaier; Hartwig Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-03       Impact factor: 4.553

7.  Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Authors:  Cindy Ke Zhou; David P Check; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Jacques Ferlay; Freddie Bray; Michael B Cook; Susan S Devesa
Journal:  Int J Cancer       Date:  2015-11-27       Impact factor: 7.396

8.  The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.

Authors:  S A Grover; L Coupal; H Zowall; R Rajan; J Trachtenberg; M Elhilali; M Chetner; L Goldenberg
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

9.  The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.

Authors:  S A Grover; L Coupal; H Zowall; R Rajan; J Trachtenberg; M Elhilali; M Chetner; L Goldenberg
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

10.  Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.

Authors:  Sabina Hussain; David Gunnell; Jenny Donovan; Sean McPhail; Freddie Hamdy; David Neal; Peter Albertsen; Julia Verne; Peter Stephens; Caroline Trotter; Richard M Martin
Journal:  BJU Int       Date:  2008-01-10       Impact factor: 5.588
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.